Cardiff Oncology Stock Technical Analysis
| CRDF Stock | USD 2.61 0.07 2.76% |
As of the 1st of December, Cardiff Oncology shows the Risk Adjusted Performance of 0.0577, downside deviation of 7.32, and Mean Deviation of 3.82. Cardiff Oncology technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Cardiff Oncology value at risk, and the relationship between the jensen alpha and semi variance to decide if Cardiff Oncology is priced correctly, providing market reflects its regular price of 2.61 per share. Please also double-check Cardiff Oncology total risk alpha, which is currently at (0.60) to validate the company can sustain itself at a future point.
Cardiff Oncology Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Cardiff, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to CardiffCardiff |
Cardiff Oncology Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 7.33 | Strong Buy | 5 | Odds |
Most Cardiff analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Cardiff stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Cardiff Oncology, talking to its executives and customers, or listening to Cardiff conference calls.
Cardiff Oncology technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Cardiff Oncology Technical Analysis
The output start index for this execution was one with a total number of output elements of sixty. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Cardiff Oncology volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Cardiff Oncology Trend Analysis
Use this graph to draw trend lines for Cardiff Oncology. You can use it to identify possible trend reversals for Cardiff Oncology as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Cardiff Oncology price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Cardiff Oncology Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Cardiff Oncology applied against its price change over selected period. The best fit line has a slop of 0.01 , which means Cardiff Oncology will continue generating value for investors. It has 122 observation points and a regression sum of squares at 2.29, which is the sum of squared deviations for the predicted Cardiff Oncology price change compared to its average price change.About Cardiff Oncology Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Cardiff Oncology on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Cardiff Oncology based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Cardiff Oncology price pattern first instead of the macroeconomic environment surrounding Cardiff Oncology. By analyzing Cardiff Oncology's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Cardiff Oncology's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Cardiff Oncology specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2021 | 2022 | 2023 | 2024 (projected) | Dividend Yield | 1.02E-4 | 0.006782 | 0.0078 | 0.00741 | Price To Sales Ratio | 653.4 | 158.13 | 135.5 | 201.15 |
Cardiff Oncology December 1, 2024 Technical Indicators
Most technical analysis of Cardiff help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Cardiff from various momentum indicators to cycle indicators. When you analyze Cardiff charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0577 | |||
| Market Risk Adjusted Performance | 0.2934 | |||
| Mean Deviation | 3.82 | |||
| Semi Deviation | 5.99 | |||
| Downside Deviation | 7.32 | |||
| Coefficient Of Variation | 1559.86 | |||
| Standard Deviation | 5.69 | |||
| Variance | 32.4 | |||
| Information Ratio | 0.0399 | |||
| Jensen Alpha | 0.1951 | |||
| Total Risk Alpha | (0.60) | |||
| Sortino Ratio | 0.0311 | |||
| Treynor Ratio | 0.2834 | |||
| Maximum Drawdown | 41.21 | |||
| Value At Risk | (8.03) | |||
| Potential Upside | 9.48 | |||
| Downside Variance | 53.56 | |||
| Semi Variance | 35.91 | |||
| Expected Short fall | (3.97) | |||
| Skewness | (0.92) | |||
| Kurtosis | 5.54 |
Complementary Tools for Cardiff Stock analysis
When running Cardiff Oncology's price analysis, check to measure Cardiff Oncology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cardiff Oncology is operating at the current time. Most of Cardiff Oncology's value examination focuses on studying past and present price action to predict the probability of Cardiff Oncology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cardiff Oncology's price. Additionally, you may evaluate how the addition of Cardiff Oncology to your portfolios can decrease your overall portfolio volatility.
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |